Search Header Logo

DENOCI

Authored by Anonymous Anonymous

Professional Development

Professional Development

Used 1+ times

DENOCI
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

13 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

What is the sequence of steps for bone remodelling?

Activation, resorption, reversal, formation, and termination
Activation, quiescence, resorption, reversal, formation, and termination
Quiescence, activation, reversal, resorption, formation, and termination
Quiescence, activation, formation, resorption, reversal, and termination

2.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

What among the below is false for Bisphosphonates?

Flu like symptoms
Supplementation of Ca & Vit. D
Extensive use in renal compromised patients
All of the above

3.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

What is the concentration of Denosumab in the vial of Denoci?

60mg/1.7ml
120mg/1.7ml
120mg/2.7ml
60mg/2.7ml

4.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

The following are the Pt Type -Denoci -------------- Except

Newly diagnosed pts with BM
Pts. who have experienced SRE
Patients previously treated with BPs & at risk of SREs
Pts Previously failed for DMARDs Treatment
Pts. with compromised renal function

5.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

The following are SRE related Events ( Clinically Significant/Serious Consequenses of Bine Metastases)…...... Except?

Broken Fractures
A Need for Bone Surgery
A Need for Radiation treatments to the Bone
Pressure on Spinal Cord(Compression)
osteoporosis

6.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

Denosumab Benefits are-

Convenience of sc dosing q4w
No dose adjustments/monitoring required
Can be used in renal impaired patients
Rare acute-phase reactions occur after denosumab
Greater suppression of bone turnover markers

7.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

Approved Indication of Denosumab

Prevention of SRE in Pts with MM and In pts with BM from Solid tumours
Treatment of Hypercalcemia of Malignancy refractory to bisphosphonates therapy
Both A and B

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?

Discover more resources for Professional Development